Literature DB >> 4003170

Evidence for defective myoblasts in Duchenne muscular dystrophy.

H M Blau, C Webster, G K Pavlath, C P Chiu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4003170     DOI： 10.1007/978-1-4684-4907-5_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  14 in total

1.  Muscle satellite cells from GRMD dystrophic dogs are not phenotypically distinguishable from wild type satellite cells in ex vivo culture.

Authors:  Zachary Berg; Lucas R Beffa; Daniel P Cook; D D W Cornelison
Journal:  Neuromuscul Disord       Date:  2011-01-28       Impact factor: 4.296

2.  The effects of three-dimensional cell culture on single myoblasts.

Authors:  Michele L Marquette; Diane Byerly; Marguerite Sognier
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-02-01       Impact factor: 2.416

3.  A novel in vitro three-dimensional skeletal muscle model.

Authors:  Michele L Marquette; Diane Byerly; Marguerite Sognier
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-09-05       Impact factor: 2.416

4.  Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle.

Authors:  Judith Lorant; Charlotte Saury; Cindy Schleder; Florence Robriquet; Blandine Lieubeau; Elisa Négroni; Isabelle Leroux; Lucie Chabrand; Sabrina Viau; Candice Babarit; Mireille Ledevin; Laurence Dubreil; Antoine Hamel; Armelle Magot; Chantal Thorin; Laëtitia Guevel; Bruno Delorme; Yann Péréon; Gillian Butler-Browne; Vincent Mouly; Karl Rouger
Journal:  Mol Ther       Date:  2017-10-20       Impact factor: 11.454

5.  The myoblast defect identified in Duchenne muscular dystrophy is not a primary expression of the DMD mutation. Clonal analysis of myoblasts from five double heterozygotes for two X-linked loci: DMD and G6PD.

Authors:  C Webster; G Filippi; A Rinaldi; C Mastropaolo; M Tondi; M Siniscalco; H M Blau
Journal:  Hum Genet       Date:  1986-09       Impact factor: 4.132

Review 6.  Overactive bone morphogenetic protein signaling in heterotopic ossification and Duchenne muscular dystrophy.

Authors:  SongTing Shi; David J J de Gorter; Willem M H Hoogaars; Peter A C 't Hoen; Peter ten Dijke
Journal:  Cell Mol Life Sci       Date:  2012-07-04       Impact factor: 9.261

7.  Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy.

Authors:  Dwi U Kemaladewi; Willem M H Hoogaars; Sandra H van Heiningen; Samuel Terlouw; David J J de Gorter; Johan T den Dunnen; Gert Jan B van Ommen; Annemieke Aartsma-Rus; Peter ten Dijke; Peter A C 't Hoen
Journal:  BMC Med Genomics       Date:  2011-04-20       Impact factor: 3.063

8.  Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia.

Authors:  William Duddy; Stephanie Duguez; Helen Johnston; Tatiana V Cohen; Aditi Phadke; Heather Gordish-Dressman; Kanneboyina Nagaraju; Viola Gnocchi; SiewHui Low; Terence Partridge
Journal:  Skelet Muscle       Date:  2015-05-01       Impact factor: 4.912

9.  Bmi1 enhances skeletal muscle regeneration through MT1-mediated oxidative stress protection in a mouse model of dystrophinopathy.

Authors:  Valentina Di Foggia; Xinyu Zhang; Danilo Licastro; Mattia F M Gerli; Rahul Phadke; Francesco Muntoni; Philippos Mourikis; Shahragim Tajbakhsh; Matthew Ellis; Laura C Greaves; Robert W Taylor; Giulio Cossu; Lesley G Robson; Silvia Marino
Journal:  J Exp Med       Date:  2014-12-01       Impact factor: 14.307

Review 10.  Splicing therapy for neuromuscular disease.

Authors:  Andrew G L Douglas; Matthew J A Wood
Journal:  Mol Cell Neurosci       Date:  2013-04-28       Impact factor: 4.314
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.